The North American Spine Society (NASS) 2023 conference in Los Angeles, California, brought together a diverse group of medical professionals, including surgeons, medical device manufacturers, and marketers. Among the highlights of this year’s event was Doctech.live‘s exclusive interview with Jeff Mathews, a representative from Zavation. The interview delved into Zavation’s merger with CoreLink and their vision for the future of spinal implant technology. In this blog post, we will explore the key highlights of this insightful conversation.
The Merger: Creating a Vertically Integrated Powerhouse
Zavation, a medical device company with a mission to provide market-leading spinal solutions, recently merged with CoreLink, another major player in the field. Jeff Mathews explained the significance of this merger, stating, “We took two manufacturing companies that are now together, and our plan is to be the most vertically integrated company in the country.” This merger, aimed at streamlining operations and expanding their product offerings, sets the stage for Zavation to make a significant impact in the spinal implant technology space.
Focus on Surgeons and Patients
Throughout the interview, it was evident that Zavation places a strong emphasis on the needs of both surgeons and patients. Mathews stressed, “Our main focus is to make sure we give and release products to surgeons that are best for their patients and their practices.” This patient-centric approach underscores their commitment to improving the quality of life for individuals requiring spinal procedures.
Flagship Products: Innovation in Spinal Solutions
Zavation’s product portfolio boasts a range of innovative solutions, with a particular focus on corpectomy and expandable cages. Their flagship product, the Easy Span Core Link, features state-of-the-art lateral technology. Mathews also hinted at their new modular screw system, designed to offer comprehensive options to surgeons, from open cases to minimally invasive procedures.
A Tour of Innovation: Easy Span Posterior Cage
During the interview, Mathews provided a glimpse of one of Zavation’s flagship products, the Easy Span Posterior Cage. He described it as “extraordinary for our surgeons and our distributors.” This posterior cage boasts expanding technology and smoothness, factors highly valued by surgeons and representatives alike. The product’s versatility and performance are indicative of Zavation’s commitment to providing cutting-edge solutions.
The Future of Zavation
When asked about the future, Mathews stated, “We’re excited about this. This is a huge opportunity for us, and I think a huge opportunity for the industry.” Zavation’s plans include further product development and integration between the two merged companies. They aim to stay ahead of the curve and become industry leaders rather than followers, a goal driven by their dedication to innovation.
State-of-the-Art Manufacturing Facilities
What sets Zavation apart is their vertically integrated manufacturing approach. Mathews explained that they handle every aspect of their products in-house, from raw materials to finished products, all proudly made in the United States. With facilities in St. Louis, Missouri, and Flowood, Mississippi, they offer surgeons a unique opportunity to witness the entire production process, emphasizing transparency and quality control.
Training for Success
Zavation places a strong emphasis on training and education. Their medical education director, Claire Strand, oversees rigorous training programs that include hands-on experience with products and cadaver labs. By equipping their representatives and distributors with in-depth knowledge, Zavation ensures that the products they offer meet the highest standards of quality and performance.
Networking and Collaboration
Zavation’s commitment to networking with surgeons and helping them build their practices sets them apart. They aim to be an integral part of the surgeon’s journey, providing support and confidence in their products and services. This collaborative approach creates a win-win situation, benefiting both surgeons and Zavation.
Conclusion
Zavation’s interview at NASS 2023, conducted by Doctech.live, shed light on their ambitious vision for the future of spinal implant technology. Their merger with CoreLink, patient-centric approach, innovative product portfolio, and commitment to education and collaboration make them a notable player in the medical device industry. As they continue to expand and innovate, Zavation is poised to make a significant impact on the field of spinal surgery, ultimately improving the lives of patients worldwide.
